期刊文献+

呼吸科病房真菌性肠炎感染分析 被引量:2

Fungal Enteritis in Respiratory Ward:A Clinical Study
原文传递
导出
摘要 目的探讨真菌性肠炎在呼吸科病房的发病相关因素、临床表现及治疗,提高对该病的认识,并制定治疗和预防方案。方法对7年来呼吸科住院患者发生真菌性肠炎的年龄、基础疾病、危险因素、诊断与治疗及预后进行回顾性调查与统计学分析。结果 5800例患者中共发生真菌性肠炎12例,在呼吸科住院患者中发病率为0.2%,均患有较严重的基础疾病;免疫力下降,较长时间使用广谱抗菌药及接受大剂量肾上腺皮质激素治疗以及化疗等因素是主要诱因,均存有菌群失调,部分患者愈后极差,12例中有3例死亡,病死率为16.6%。结论防治真菌性肠炎应采取综合性措施,包括合理使用抗菌药和肾上腺皮质激素,防治菌群失调,缩短住院时间等,对该病应早期诊断与治疗。 OBJECTIVE To approach the clinical correlation factors and morbidity of fungal enteritis with inpatients in the respiratory ward,clinical manifestation,diagnosis treatment and prognosis.To enhance the understanding of this disease and to institute the plan of prevention and treatment.METHODS The age,underlying diseases,risk factors,diagnosis,treatment and prognosis of fungal enteritis in the 5800 inpatients were reviewed retrospectively and analyzed statistically.RESULTS There were 12 cases suffered from fungal enteritis,the morbidity was 0.2%.All of fungal enteritis had several underlying diseases and risk factors,hypoimmunity,using broad-spectrum antibacterials for a long time,receiving large dosage glucocorticoid or other chemotherapy.The fungal enteritis in all of the patients with dysbacteriosis belonged to deep fungal infection,parts of these cases had poor prognosis,3 cases were dead among the 12 patients,the mortality was 16.6%.CONCLUSION The comprehensive measures should be adopted in prevention and treatment of fungal enteritis,which include the rational application of antibiotics and adrenocortical steroid,the prevention and treatment of dysbacteriosis,shortening the time of stay in hospital,early diagnosis and treatment,rational using antifungals and others.
作者 余更生 蒋萍
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2010年第16期2423-2425,共3页 Chinese Journal of Nosocomiology
关键词 真菌性肠炎 腹泻 危险因素 菌群失调 抗真菌药 Fungal enteritis Diarrhea Risk factors Dysbacteriosis Antifungals
  • 相关文献

参考文献6

二级参考文献21

  • 1王付彬.真菌性肠炎198例临床分析[J].中国全科医学,2005,8(6):494-494. 被引量:5
  • 2任宏宇,易粹琼.原生菌的生物学特性、作用和临床[J].临床消化病杂志,2005,17(3):141-143. 被引量:4
  • 3陈春雷,李兰娟.感染微生态学的研究进展[J].国外医学(流行病学.传染病学分册),2005,32(5):271-273. 被引量:25
  • 4陈平.抗真菌药物的不良反应[J].医师进修杂志,2005,28(11):12-14. 被引量:8
  • 5Sarah M, Bassel A, Sandra W. Candida albicans zinc cluster protein Upc2p confers resistance to antifungal drugs and is an activator of ergosterol biosynthetic genes[J]. Antimicrob Agents Chemother, 2005,49(5) : 1745-1752.
  • 6White TC, Holleman S, Dy F, et al. Resistance mechanisms in clinical isolates ofCandidaalbicans[J]. Antimicrob Agents Chemother, 2002,46(6) : 1704 -1713.
  • 7Vermitsky JP, Edlind TD. Azole Resistance in Candida glabrata:coordinate upregulation of multidrug transporters and evidence for a Pdrl-like transcription factor[J]. Antimicrob Agents Chemother, 2004,3773-3781.
  • 8Pinion E, Jackson CJ, Kelly SL. Reduced azole susceptibility in genotype 3 Candida dubliniensis isolates associated with increased CdCDR1 and CdCDR2 expression[J]. Antimicrob Agents Chemother, 2005,49(4) : 1312-1318.
  • 9Hiller D, Sanglard D, Morschhauser J. Overexpression of the MDR1 gene is sufficient to confer increased resistance to toxic compounds in Candida albicans[J]. Antimierob Agents Che mother, 2006,50(4) : 1365-1371.
  • 10Pinjon E, Moran GP, Jackson CJ. Molecular mechanisms of itraconazole resistance in Candida dubliniensis [J]. Antimicrob Agents Chemother, 2003,47(8) :2424-2437.

共引文献19

同被引文献13

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部